Evaluation of Improvements in Patient-reported Quality of Life

Recruiting now · Not applicable

Conditions studied: Breast Cancer, Quality of Life, Physical Activity, Sleep Quality, Stress, Pain

In brief

Local intervention trial for the evaluation of improvements in patient-reported Quality of Life and treatment satisfaction, in breast cancer patients (BCP), as a result of flexible treatment planning supported by REBECCA-collected real-world data, in comparison with standard care

Key facts

Study ID

NCT06002022

Run by

Fundación para la Investigación del Hospital Clínico de Valencia

People needed

110

Starts

2024-01-01

Expected to finish

2025-12-31

Last updated by the study team

2025-08-06

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Before patient registration, written informed consent must be given according to national and local regulations.
• Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization.
• Be between 18 and 75 years of age.
• Have increased life expectancy beyond the initial 3 months post-treatment initiation.
• Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.
• Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.

You may not qualify if…

• Patients that are not willing to sign an informed consent form

Where it is running

• Hospital Clínico Universitario de Valencia — Valencia, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.